Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM CMR substudy analysis

Tools

Item Type:	Letter
Title:	Mavacamten favorably impacts cardiac structure in obstructive hypertrophic cardiomyopathy: EXPLORER-HCM CMR substudy analysis
Creators Name:	Saberi, S., Cardim, N., Yamani, M.H., Schulz-Menger, J., Li, W., Florea, V., Sehnert, A.J., Kwong, R.Y., Jerosch-Herold, M., Masri, A., Owens, A., Lakdawala, N.K., Kramer, C.M., Sherrid, M., Seidler, T., Wang, A., Sedaghat-Hamedani, F., Meder, B., Havakuk, O. and Jacoby, D.
Keywords:	Benzylamines, Hypertrophic Cardiomyopathy, Cine Magnetic Resonance Imaging, Uracil, Uracil / Therapeutic Use
Source:	Circulation
ISSN:	0009-7322
Publisher:	American Heart Association
Volume:	143
Number:	6
Page Range:	606-608
Date:	9 February 2021
Official Publication:	https://doi.org/10.1161/CIRCULATIONAHA.120.052359
PubMed:	View item in PubMed

Repository Staff Only: item control page